Watton Corey Michael
SEC insider (Form 3/4/5 filer). CIK 0001975404. Director at ZEVRA THERAPEUTICS, INC. (ZVRA). 6 reported Form 4/5 transactions since Sep 2024; latest on Aug 10, 2026. Located in BOSTON, MA.
Companies Watton Corey Michael has filed insider reports for
- ZEVRA THERAPEUTICS, INC. (ZVRA): Director
Watton Corey Michael
CIK: 0001975404
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
ZEVRA THERAPEUTICS, INC.
Discretionary Trading P&L
Holdings
Transaction History (6 total)
- Aug 10, 2026ZVRA
ZEVRA THERAPEUTICS, INC.
ExerciseDirect12.3K shares at avg. $4.97$61K - Aug 10, 2026ZVRA
ZEVRA THERAPEUTICS, INC.
SaleDirect12.3K shares at avg. $11.25$138K - Jun 4, 2026ZVRA
ZEVRA THERAPEUTICS, INC.
AwardDirectStock Option (right to buy)
30K shares- - May 29, 2025ZVRA
ZEVRA THERAPEUTICS, INC.
AwardDirectStock Option (right to buy)
30K shares- - Mar 28, 2025ZVRA
ZEVRA THERAPEUTICS, INC.
PurchaseDirect300 shares at avg. $7.84$2K - Oct 11, 2024ZVRA
ZEVRA THERAPEUTICS, INC.
PurchaseDirect500 shares at avg. $7.92$4K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Aug 10, 2026 | ZVRA ZEVRA THERAPEUTICS, INC. | Exercise | 12,300 | $4.97 | $61,131 | Direct |
| Aug 10, 2026 | ZVRA ZEVRA THERAPEUTICS, INC. | Sale | 12,300 | $11.25 | $138,377 | Direct |
| Jun 4, 2026 | ZVRA ZEVRA THERAPEUTICS, INC. | Award Stock Option (right to buy) | 30,000 | - | - | Direct |
| May 29, 2025 | ZVRA ZEVRA THERAPEUTICS, INC. | Award Stock Option (right to buy) | 30,000 | - | - | Direct |
| Mar 28, 2025 | ZVRA ZEVRA THERAPEUTICS, INC. | Purchase | 300 | $7.84 | $2,352 | Direct |
| Oct 11, 2024 | ZVRA ZEVRA THERAPEUTICS, INC. | Purchase | 500 | $7.92 | $3,958 | Direct |
1-6 of 6 transactions